Journal of Clinical and Translational Hepatology

Article	Citations
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver	69
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD	39
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study	30
Statin-induced Liver Injury Patterns: A Clinical Review	30
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak	22
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy	22
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review	22
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome	21
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications	20
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma	19
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail	17
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis	17
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)	17
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease	17
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease	16
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update	16
Guidelines for Prevention and Treatment of Chronic Hepatitis B	15
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease	15
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges	13
Guidelines for the Management of Cholestatic Liver Diseases (2021)	13
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review	13
Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma	12
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence	12
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice	12
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates	12

Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)	11
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists	11
Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally	10
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment	10
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update	10
Update on Sphincter of Oddi Dysfunction: A Review	10
Infections in Alcoholic Hepatitis	10
Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts	10
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome	9
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies	9
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition	9
Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment	9
Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies	9
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway	9
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver	9
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease	9
Racial and Health Disparities among Cirrhosis-related Hospitalizations in the USA	9
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype	9
Selective Androgen Receptor Modulators: An Emerging Liver Toxin	9
Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City	9
A Nomogram-based Model to Predict Neoplastic Risk for Patients with Gallbladder Polyps	8
Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease	8
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis	8
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice	8
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection	8
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science	8
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases	8
Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review	8
Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease	8
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China	8
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence	8
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice	8
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A Cohort Study	8
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation	8
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?	7
Sarcopenia in Chronic Liver Disease: A Metabolic Perspective	7
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling	7
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma	7
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China	7
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis	7
Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis	7
Development and Validation of a Nomogram Based on Perioperative Factors to Predict Post-hepatectomy Liver Failure	7
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?	7
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection	7
Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome	7
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure	7
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research	7
Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis	7
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?	7
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning	7

KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis	7
Current Status and Analysis of Machine Learning in Hepatocellular Carcinoma	6
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop	6
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase	6
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination	6
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China	6
Hepatic Arterioportal Fistulas: A Retrospective Analysis of 97 Cases	6
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions	6
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study	6
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma	6
MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life	6
Hepatic Histoplasmosis: An Update	6
The Gut Microbiome and Ferroptosis in MAFLD	6
HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site	6
Expression and Regulatory Network Analysis of Function of Small Nucleolar RNA Host Gene 4 in Hepatocellular Carcinoma	6
Targeted Mitochondrial Delivery to Hepatocytes: A Review	6
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection	6
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss	5
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis	5
Integrative Characterization of Immune-relevant Genes in Hepatocellular Carcinoma	5
Regulatory Effect of JAK2/STAT3 on the Immune Function of Endotoxin-tolerant Dendritic Cells and its Involvement in Acute Liver Failure	5
Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease	5
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment	5
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions	5
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center	5
Diagnostic Accuracy of the Apparent Diffusion Coefficient for Microvascular Invasion in Hepatocellular Carcinoma: A Meta-analysis	5
Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease	5
Noncanonical NF-κB Signaling Pathway in Liver Diseases	5
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China	5
Single-center Experience in the Diagnosis and Treatment of Hepatic Perivascular Epithelioid Cell Neoplasm	5
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic	5
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)	5
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization	5
Coronavirus Disease-2019 (COVID-19) and the Liver	5
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease	5
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection	5
Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases	5
Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota	5
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019	5
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis	4
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma	4
Impact of Helicobacter pylori Infection on the Pathogenesis and Management of Nonalcoholic Fatty Liver Disease	4
Functional Cure of Chronic Hepatitis B with Antiviral Treatment in Children having High-level Viremia and Normal or Mildly Elevated Serum Aminotransferase	4
Roles of SET7/9 and LSD1 in the Pathogenesis of Arsenic-induced Hepatocyte Apoptosis	4
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma	4
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis	4
Nonalcoholic Fatty Liver Disease after Liver Transplant	4
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms	4
Seronegative Autoimmune Hepatitis	4
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review	4
Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo	4
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis	4
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma	4
Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease	4
Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians	4
Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores	4
HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters	4
Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms	4
Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice	4
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis	4
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway	4
UMSCs Attenuate LPS/D-GalN-Induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway	4
Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver	4
Hepatocellular Carcinoma: Downstaging to Liver Transplantation as Curative Therapy	4
Added Value of Quantitative Apparent Diffusion Coefficients for Identifying Small Hepatocellular Carcinoma from Benign Nodule Categorized as LI-RADS 3 and 4 in Cirrhosis	4
2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus	4
Alcohol and Metabolic-associated Fatty Liver Disease	4
Effects of Low-dose and High-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy	4
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation	4
Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease	4
Diagnostic and Prognostic Value of Protein Post-Translational Modifications in Hepatocellular Carcinoma	4
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites	4
Effect of Lactate on Epigenetic Regulation in the Development of Hepatitis B Virus-related Hepatocellular Carcinoma	3
Predictive Value of Inflammation Biomarkers in Patients with Portal Vein Thrombosis	3
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis	3
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection	3
Alcoholic Liver Disease and COVID-19 Pneumonia: A Case Series	3
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)	3
Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B	3
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir	3

Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis	3
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link	3
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis	3
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients	3
Sarmentosin Induces Autophagy-dependent Apoptosis via Activation of Nrf2 in Hepatocellular Carcinoma	3
STX5 Inhibits Hepatocellular Carcinoma Adhesion and Promotes Metastasis by Regulating the PI3K/mTOR Pathway	3
Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2	3
Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection	3
Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment	3
Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma	3
Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier	3
Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review	3
Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway In Vivo and In vitro	3
Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK	3
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B	3
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)	3
Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease	3
Hepatitis B Virus Induces Microtubule Stabilization to Promote Productive Infection through Upregulating Microtubule-associated Protein 1S	3
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome	3
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension	3
Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients	3
A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients	3
NASH Drug Development: Seeing the Light at the End of the Tunnel?	3
Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA	3
Immunotherapy-induced Hepatotoxicity: A Review	3
Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades	3
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?	3
Clinical Course and Outcome Patterns of Acute-on-chronic Liver Failure: A Multicenter Retrospective Cohort Study	3
Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-center Study	3
Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis	3
Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF	2
MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement	2
Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?	2
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia	2
Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis	2
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future	2
Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription	2
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity	2
Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Bioinformatics and the Role of NR6A1 in the Progression of HCC	2
Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China	2
Dissecting the Contributing Role of Divergent Adipose Tissue to Multidimensional Frailty in Cirrhosis	2
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations	2
Predictive Model of Oxaliplatin-induced Liver Injury Based on Artificial Neural Network and Logistic Regression	2
Hepatic Alarmins and Mitochondrial Dysfunction under Residual Hyperlipidemic Stress Lead to Irreversible NAFLD	2
Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis	2
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients	2
COVID-19 in Liver Transplant Recipients	2
COVID-19 and Liver Transplantation: Challenges and Opportunities	2
Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging	2
Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity	2
Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review	2
CircTUBD1: A Novel Circular RNA Molecule as a Therapeutic Target in Radiation-induced Liver Fibrosis	2
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis	2
Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update	2
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma	2
Emerging Therapeutic Strategies in the Fight Against Primary Biliary Cholangitis	2
Acute-on-chronic Liver Failure in a Patient with Candida Endophthalmitis: A Case Report	2
Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India	2
Imaging Findings of Hepatic Ewing’s Sarcoma on Computed Tomography and Gadobenate Dimeglumine-enhanced Magnetic Resonance Imaging: A Case Report and Literature Review	2
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment	2
Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis	2
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes	2
Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis	2
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate	2
Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis	2
Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors	2
Prediction and Prevention of Post-hepatectomy Liver Failure: Where Do We Stand?	2
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades	2
An Update on Efficacy and Safety of Emerging Hepatic Antifibrotic Agents	2
Integrated Multidisciplinary Management of Alcohol-Associated Liver Disease	2
Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest	2
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population	2
UGT1A1-related Bilirubin Encephalopathy/Kernicterus in Adults	2
PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure	2
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence	2
Targeting Gut Microbiota for the Treatment of Primary Biliary Cholangitis: From Bench to Bedside	2
Clinical Prediction Models for Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Technical Report	2
Celiac Disease and Elevated Liver Enzymes: A Review	2
IL-33 Downregulates Hepatic Carboxylesterase 1 in Acute Liver Injury via Macrophage-Derived Exosomal miR-27b-3p	2
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement	2
Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma	2
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity	2
Endoscopic Bariatric and Metabolic Therapies for Liver Disease: Mechanisms, Benefits, and Associated Risks	2
Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification	2
Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosis	2
CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis	2
High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico	2
Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury	2
An Ecological Evaluation of Vinyl Chloride Exposure and Liver Cancer Incidence and Mortality in Texas	2
Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases	2
Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multice	2
Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital	2
A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma	2
USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells	2
Application and Progress of Cultured Models of Gallbladder Carcinoma	2